We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $22.1B
1-Year Est. Return 45.54%
This Fund
S&P 500
This Quarter Est. Return
+9.12%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
AUM
$13.2B
AUM Growth
+$1.19B
Cap. Flow
+$398M
Cap. Flow %
3.01%
Top 10 Hldgs %
25.15%
Holding
2,888
New
90
Increased
233
Reduced
1,480
Closed
57

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$33.4M
2
AAPL icon
Apple
AAPL
+$20.4M
3
MSFT icon
Microsoft
MSFT
+$10.9M
4
TWTR
Twitter, Inc.
TWTR
+$9.15M
5
Y
Alleghany Corp
Y
+$7.32M

Sector Composition

Rank Sector Weight
1 Technology 19.64%
2 Healthcare 13.35%
3 Financials 12.18%
4 Consumer Discretionary 9.16%
5 Industrials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRO icon
1626
Frontline
FRO
$9.02B
$514K ﹤0.01%
42,361
-23,524
-36% -$302K
APOG icon
1627
Apogee Enterprises
APOG
$897M
$514K ﹤0.01%
11,557
-893
-7% -$40.3K
CRNX icon
1628
Crinetics Pharmaceuticals
CRNX
$8.96B
$513K ﹤0.01%
28,047
+792
+3% +$14K
PRA
1629
DELISTED
ProAssurance
PRA
$513K ﹤0.01%
29,342
AZZ icon
1630
AZZ Inc
AZZ
$4.55B
$512K ﹤0.01%
12,727
DFIN icon
1631
Donnelley Financial Solutions
DFIN
$1.17B
$511K ﹤0.01%
13,234
-602
-4% -$22.6K
CARS icon
1632
Cars.com
CARS
$648M
$510K ﹤0.01%
37,051
PRDO icon
1633
Perdoceo Education
PRDO
$1.96B
$510K ﹤0.01%
36,674
MRC
1634
DELISTED
MRC Global
MRC
$510K ﹤0.01%
44,004
SUMO
1635
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
$509K ﹤0.01%
62,803
LZB icon
1636
La-Z-Boy
LZB
$1.64B
$508K ﹤0.01%
22,282
-2,556
-10% -$62.1K
INVX
1637
Innovex International
INVX
$2.15B
$507K ﹤0.01%
18,666
RGNX icon
1638
Regenxbio
RGNX
$704M
$506K ﹤0.01%
22,327
-935
-4% -$21.1K
IMGO
1639
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$506K ﹤0.01%
14,080
-4,246
-23% -$106K
FLNG icon
1640
FLEX LNG
FLNG
$1.6B
$506K ﹤0.01%
15,474
HCSG icon
1641
Healthcare Services Group
HCSG
$1.43B
$505K ﹤0.01%
42,076
BHE icon
1642
Benchmark Electronics
BHE
$2.94B
$504K ﹤0.01%
18,876
-769
-4% -$21.3K
ZNTL icon
1643
Zentalis Pharmaceuticals
ZNTL
$297M
$502K ﹤0.01%
24,936
IOVA icon
1644
Iovance Biotherapeutics
IOVA
$2.95B
$502K ﹤0.01%
78,571
CCRN
1645
DELISTED
Cross Country Healthcare
CCRN
$502K ﹤0.01%
18,894
-801
-4% -$26.1K
CNK icon
1646
Cinemark Holdings
CNK
$4.37B
$502K ﹤0.01%
57,967
ACVA icon
1647
ACV Auctions
ACVA
$1.35B
$502K ﹤0.01%
61,086
-17,631
-22% -$147K
ZETA icon
1648
Zeta Global
ZETA
$7.44B
$501K ﹤0.01%
61,368
GTM
1649
ZoomInfo Technologies
GTM
$1.25B
$500K ﹤0.01%
16,616
-437
-3% -$15.1K
KYMR icon
1650
Kymera Therapeutics
KYMR
$9.51B
$498K ﹤0.01%
19,965
-2,273
-10% -$60.6K

Similar funds

MetLife Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, MetLife Investment Management held 2,888 positions worth $13.2B, up 9.9% from $12B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management deployed $398M of net new capital in Q4 2022, opening 90 new positions and adding to 233 existing holdings. Its largest new stake was Atlassian: 8,691 shares worth $1.12M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $33.4M trimmed.

  • MetLife Investment Management's largest Q4 2022 buy was Atlassian: 8,691 shares worth $1.12M.
  • MetLife Investment Management added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2022, an estimated $651M increase.
  • MetLife Investment Management's biggest Q4 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $33.4M.
  • MetLife Investment Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $9.15M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $13.2B portfolio in Q4 2022.
  • MetLife Investment Management opened 90 new positions and closed 57 in Q4 2022.
  • MetLife Investment Management's portfolio value rose 9.9% quarter-over-quarter to $13.2B.

Based on MetLife Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.